Dumato, Mecah Ella A.

HRN: 21-64-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2022
CEFUROXIME 750MG (VIAL)
07/20/2022
07/26/2022
IVT
200mg
Q8
PCAP C
Waiting Final Action 
07/21/2022
CEFTRIAXONE 1G (VIAL)
07/21/2022
07/27/2022
IVT
600mg
OD
PCAP C
Waiting Final Action 
07/21/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
07/21/2022
07/26/2022
ORAL
1.5 Ml
24 Hrs
PCAP C
Waiting Final Action 
07/25/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/25/2022
08/01/2022
IV
225mg
Q6h
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: